Damaged gene FBXO28 is linked to patient at TGen’s Center for Rare Childhood DisordersContinue reading
Author Archive: AZBio
The Fostering Innovation Act and the HALOS Act pass in the U.S. House of Representatives
The House of Representatives on July 17, 2018 passed two bills designed to better equip job creators in our state to grow and thrive.Continue reading
TGen-led study shows DNA methylation related to liver disease among obese patients
Potentially deadly NAFLD associated with genetic changes; potential drug targets identifiedContinue reading
TGen opens DIPG tissue donation portal to accelerate research
New donations support research into this fast-moving brain cancerContinue reading
NuvOx Pharma Receives $2M SBIR Grant for Pancreatic Cancer Diagnostic Development
Evan Unger, MD, President and CEO of NuvOx Pharma, announced that NuvOx has received a $2M Phase II Small Business Innovation Research (SBIR) grant from the National Cancer Institute to fund the development of a new strategy to detect pancreatic cancer. Continue reading
Medical tech company will anchor I.D.E.A. Tempe campus
One of the largest medical technology companies in the world will be the first tenant for the new I.D.E.A. Tempe campus. The Peripheral Intervention business of BD (Becton, Dickinson and Company) will be the first tenant in a new building at the Tempe Town Lake development. It will open in late 2019. Continue reading
Mary O’Reilly named new Flinn Foundation Vice President, Bioscience Research Programs
Mary O’Reilly, Ph.D., a philanthropy executive with extensive industry and laboratory experience, has been named the new Vice President, Bioscience Research Programs at the Flinn Foundation, where she will help implement grantmaking programs and other activities designed to advance Arizona’s bioscience sector.Continue reading
IsoRay Announces FDA Clearance of GammaTile™ Therapy for the Treatment of Recurrent Brain Neoplasms
GammaTile Therapy is the Next Step in the Expansion of Cesium to Additional MarketsContinue reading